Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00443274 · ClinicalTrials.gov registry record

Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms

A clinical trial of Breast Implant, sponsored by Allergan.

Active
Registry status
56,460
Enrollment target
1
Study location

NCT00443274: Active study of Breast Implant, sponsored by Allergan.

NCT00443274 is a study of Breast Implant that is active but no longer recruiting, run by Allergan. The registered enrollment target is 56,460 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00443274, a study of Breast Implant, is active but no longer recruiting, sponsored by Allergan.

ACTIVE NOT RECRUITING
Registry status
56,460 participants
Enrollment target
1
Study location

Study Summary

Ten year safety study examining rates of rare adverse events, child bearing issues, effects of mammography, MRI compliance and results, and long-term benefit of silicone-filled breast implants.

Conditions Studied

Interventions

  • OTHER NBIR - US National Breast Implant Registry
  • DEVICE 410 Arm
  • DEVICE BIFs - Breast Implant Follow-Up Study

Study Locations (1)

Texas

  • Southwest Plastic Surgery /ID# 240510 - El Paso

Trial Details

FieldValue
Enrollment Target 56,460 participants
Start Date 2006-11-01
Est. Completion 2029-12-31
Allergan

314 total trials

What the registry record for NCT00443274 still lists

NCT00443274 is an observational study that tracks outcomes without assigning an intervention. Its 56,460 participants enrollment target places it among the larger protocols in the corpus.

The record links to 1 condition, with Breast Implant appearing as the primary indexed condition, and to 3 interventions - of which NBIR - US National Breast Implant Registry is the first listed.

NCT00443274 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT00443274 about?

NCT00443274 is a clinical study titled "Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms". Ten year safety study examining rates of rare adverse events, child bearing issues, effects of mammography, MRI compliance and results, and long-term benefit of silicone-filled breast implants.

What is the current status of trial NCT00443274?

This trial is currently active not recruiting. The enrollment target is 56,460 participants. The study started on 2006-11-01. Estimated completion is 2029-12-31.

What conditions does trial NCT00443274 study?

This clinical trial studies the following conditions: Breast Implant.

What interventions are being tested in trial NCT00443274?

The interventions under investigation include: NBIR - US National Breast Implant Registry (OTHER), 410 Arm (DEVICE), BIFs - Breast Implant Follow-Up Study (DEVICE).

Who is sponsoring clinical trial NCT00443274?

This trial is sponsored by Allergan, which has 314 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00443274 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Implant

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07224243 · 54,000 participants · NA

    Impact of Intraoperative Oxygenation Practices on Patient Outcomes

  • NCT00785525 · 60,000 participants · Phase 3

    Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors

  • NCT01825499 · 60,000 participants

    Vermont Oxford Network Very Low Birth Weight Database

  • NCT02850588 · 60,000 participants

    SVS VQI TransCarotid Revascularization Surveillance Project

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00443274, the US trial registry maintained by the National Library of Medicine. NCT00443274 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.